Prognostic impact of severe postoperative complications after curative-intent resection for perihilar cholangiocarcinoma: an international multi-institutional analysis.
The association between severe postoperative complications and long-term outcomes appeared more evident among patients with more favorable tumor biology, and was more evident among patients with more favorable tumor biology.
Abstract
INTRODUCTION
We sought to evaluate the impact of severe postoperative complications on recurrence-free survival (RFS) after curative-intent resection for pCCA with particular attention to tumor biology.
Methods
An international multi-institutional database was queried to identify patients who underwent curative-intent liver resection for pCCA between 2000 and 2023. Patients who died within 90 days of surgery were excluded. Severe complications were defined as Clavien-Dindo grade ≥ III.
Results
Among 453 patients, the median age was 67 years (IQR, 57-74), 62.3% were male, 29.3% had CA19-9 ≥400 U/mL, and 36.6% experienced severe postoperative complications. Overall, 3-year RFS was worse among patients with severe complications versus those without (26.7% vs 30.7%; p = 0.044). This association was more pronounced among patients with CA19-9 <400 U/mL (25.4% vs 32.9%; p = 0.014), whereas no difference was observed among patients with CA19-9 ≥400 U/mL (28.3% vs 24.9%; p = 0.88). On multivariable analysis, severe complications remained independently associated with worse RFS among patients with CA19-9 <400 U/mL (HR 1.39, 95% CI 1.03-1.88; p = 0.03), but not among individuals with CA19-9 ≥400 U/mL (HR 0.78, 95% CI 0.48-1.28; p = 0.32). On sensitivity analyses using a Fine-Gray competing risk model, severe postoperative complications were not independently associated with recurrence in either subgroup.
Conclusions
The association between severe postoperative complications and long-term outcomes appeared more evident among patients with more favorable tumor biology.
CD ≥3 complications independently worsen RFS, OS, and CSS but do not significantly affect TTR after curative resection for pStage I-III CRC, suggesting that severe complications may not primarily accelerate recurrence itself, but may instead impair survival after recurrence, highlighting possible mechanisms beyond dire...
S. Hashimoto, T. Tominaga, Keisuke Noda et al.· Japanese Journal of Clinical...· 0 citations
BACKGROUND
The significance of indeterminate pulmonary nodules (IPNs) at the time of definitive surgical resection of colorectal liver metastases (CRLM) is not well understood. We examined how the presence of IPNs at the time of resection of liver metastases impacts clinical outcomes and identified predictive factors f...
H. C. Wilbur, Heng-Chung Kung, Reena S. Suresh et al.· Journal of Gastrointestinal...· 0 citations
Children with advanced hepatoblastoma (PRETEXT III-IV) often require complex surgical decision-making; however, contemporary data describing long-term outcomes and recurrence patterns across the full spectrum of definitive surgery remain limited. We included 68 patients with PRETEXT III and IV who underwent definitive...
Sagar Mehta, B. Sayed, Furqan Shaikh et al.· Liver transplantation· 0 citations
INTRODUCTION
Parenchymal-sparing one-stage hepatectomy (POSH) has expanded surgical eligibility for patients with high-burden (≥10) colorectal liver metastases (CLM). Early recurrence (ER), defined as recurrence within 6 months, remains a challenge, and its prognostic significance and preoperative predictability in thi...
F. Milana, F. Procopio, G. Rodda et al.· European Journal of Surgical...· 0 citations
Abstract Background Gastric cancer remains a major health burden in Slovenia, particularly among elderly patients. With increasing life expectancy, a growing number of patients aged ≥ 70 years are expected to undergo curative surgery. This study compared clinical, surgical, and oncologic outcomes between elderly (≥ 70...
M. Horvat, S. Potrč, N. Arslani· Radiology and Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.